A global executive summit focused on the commercialization, regulation, infrastructure, and investment landscape driving the future of precision neuroscience and Neuro-AI markets.
Who You'll Meet
Ryota Kanai
Araya, Inc.
Maro Machizawa
Xiberlinc
Allan McCay
The University of Sydney
Marcello Ienca
Technical University of Munich
View speakers →
NEURO-LOGIC 2027 is a commercial forum at the intersection of computational neuroscience, brain-computer interfaces (BCI), and global capital. As the flagship event in the Synerg Events portfolio, it serves as the critical bridge between cutting-edge “mind-machine” innovation and scalable clinical and pharmaceutical deployment.
In a market where neurotechnology and AI-driven brain health solutions are poised for explosive growth, NEURO-LOGIC 2027 focuses exclusively on commercialization, regulation, investment, and scaling. We move decisively beyond scientific discovery to the practical realities of deal-making, regulatory pathways, reimbursement strategies, and go-to-market execution, accelerating the partnerships and capital flows that will shape the next decade of precision brain health.
This is not another academic conference. It is a tightly curated business summit engineered for senior decision-makers who are actively deploying capital, acquiring technologies, and bringing neuro-AI solutions to market.
EXECUTIVE PARTICIPATION
Network with a strictly capped audience of 250–300 C-level executives, investors, and innovators.
Receive direct insight into pharmaceutical M&A pipelines, VC investment priorities, and emerging Neuro-AI commercialization trends.
Engage with policymakers and regulators shaping AI-driven neurotechnology, SaMD frameworks, and neural privacy standards.
Access pre-vetted startups positioned for Series A–C investment, strategic partnerships, and acquisition opportunities.
C-Suite Executives and Founders from high-growth Neuro-AI, BCI, and digital neurology companies.
Heads of R&D, Innovation, Business Development, and M&A from leading global pharmaceutical firms.
Venture Capital, Private Equity, Corporate Venture, and Sovereign Wealth Fund investors.
Technology leaders across AI infrastructure, hyperscalers, neuro-hardware, and cloud platforms.
Regulators, policymakers, and bioethics experts from APAC, Europe, and North America.
SUMMIT PROGRAM
Monday, July 12, 2027
Tuesday, July 13, 2027
Wednesday, July 14, 2027
CONFIRMED FACULTY
NEURO-LOGIC brings together neuroscience, AI, clinical development, policy, and investment leaders who are shaping how brain-health innovation reaches patients.
Apply to speakWe are curating a cross-disciplinary faculty from biopharma, neurotechnology, AI, academia, policy, and capital.
Apply to SpeakSTRATEGIC PARTNERSHIPS
Sponsoring NEURO-LOGIC 2027 delivers targeted access to the executives, investors, regulators, and innovators shaping the future of Neuro-AI, precision neuroscience, and brain-health commercialization.
Align your organization with the definitive commercial summit for Neuro-AI, BCI, and precision neuroscience. Sponsors are positioned as industry leaders, not just exhibitors.
Secure speaking opportunities, fireside discussions, or moderated panels to present your solutions directly to buyers, investors, and strategic partners.
Access private networking environments, startup showcases, and investor round-tables where partnership, funding, and acquisition discussions take place.
Demonstrate platforms, infrastructure, devices, and enterprise capabilities through demo zones, innovation showcases, and executive sessions.
Build long-term visibility through post-event media, attendee engagement, and ongoing association with NEURO-LOGIC as a flagship annual summit.
Headline Sponsorship
Strategic Visibility
Ecosystem Access
Startup & Technology Showcase
CONFIRMED VENUE
NEURO-LOGIC 2027 will take place at Hilton Singapore Orchard, bringing the precision neuroscience community together in the heart of Singapore's Orchard Road district. Delegate accommodation and arrival guidance will be shared with registered attendees.